Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-059427
Filing Date
2013-11-07
Accepted
2013-11-07 08:33:21
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v357888_10q.htm 10-Q 1404902
2 EXHIBIT 31.1 v357888_ex31-1.htm EX-31.1 11135
3 EXHIBIT 31.2 v357888_ex31-2.htm EX-31.2 11077
4 EXHIBIT 32.1 v357888_ex32-1.htm EX-32.1 7167
  Complete submission text file 0001144204-13-059427.txt   5454601

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20130930.xml EX-101.INS 684164
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20130930.xsd EX-101.SCH 42390
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20130930_cal.xml EX-101.CAL 49271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20130930_def.xml EX-101.DEF 202082
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20130930_lab.xml EX-101.LAB 298722
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20130930_pre.xml EX-101.PRE 247755
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 131198580
SIC: 2834 Pharmaceutical Preparations